---
$id: https://graph.org.ai/products/commodity/51151651
$type: Product
source: UNSPSC
code: "51151651"
title: "Methixene or metixene"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Methixene or metixene

**UNSPSC Code**: 51151651
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C20H23NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32VY6L26ZW, chemically known as 1-pipecoline, 3-(thioxanthen-9-yl)methyl-, hydrochloride but generally known as methixene, which bears US NIH Compound Identifier 4167. European Medicines Agency schedules Metixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08897MIG. The term METHIXENE is an International Non-Proprietary Name. World Health Organization schedules methixene in its Anatomical Therapeutic Chemical (ATC) Classification. Methixene or metixene bears US NLM identifiers UMLS ID C0066139 and NCI Concept Code C74162. SMILES: CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24.

